Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Integral Diagnostics Ltd. ( (AU:IDX) ) has provided an update.
Integral Diagnostics Ltd., an ASX-listed provider of diagnostic imaging services, has confirmed the issue of additional ordinary fully paid shares. The company operates in the healthcare sector, supplying radiology and diagnostic solutions to medical professionals and patients across its network.
The company has applied for quotation on the ASX of 139,874 new ordinary fully paid shares, issued on 2 April 2026 under a dividend or distribution plan. This modest increase in quoted securities slightly expands the company’s equity base and reflects the ongoing use of equity-based shareholder distribution mechanisms without signaling a major change in capital structure.
The most recent analyst rating on (AU:IDX) stock is a Hold with a A$2.50 price target. To see the full list of analyst forecasts on Integral Diagnostics Ltd. stock, see the AU:IDX Stock Forecast page.
More about Integral Diagnostics Ltd.
Integral Diagnostics Ltd. is an Australian healthcare company operating diagnostic imaging services, with a focus on providing radiology and related diagnostic solutions. The company is listed on the ASX under the ticker IDX and serves medical practitioners, hospitals, and patients through its network of imaging facilities.
Average Trading Volume: 853,862
Technical Sentiment Signal: Sell
Current Market Cap: A$879.6M
See more data about IDX stock on TipRanks’ Stock Analysis page.